News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

How HIV works news

Show

From To
How HIV works
Deoxyhypusine synthase: a new target for HIV therapy?

An inhibitor of the enzyme deoxyhypusine synthase (DHS) can suppress the replication of HIV, according to a test tube study presented in the January edition

Published
12 January 2005
By
Christopher Gadd
How HIV works
Can HIV infection occur through the lining of the mouth?

HIV from semen or breast milk can bind to and infect the cells lining the mouth and the tonsils, according to two test tube studies

Published
01 December 2004
By
Christopher Gadd
How HIV works
Dendritic-cell treatment boosts therapeutic vaccine prospects

A group of French and Brazilian researchers have claimed a possible success in boosting immune responses and controlling HIV in a clinical trial where 18

Published
30 November 2004
By
Julian Meldrum
How HIV works
AZT resistance suppression mutations can also reduce tenofovir resistance, test tube study shows (corrected)

This is a corrected version of an article originally published on aidsmap.com on Friday, 19 November 2004. Mutations in HIV that suppress AZT (zidovudine, Retrovir) resistance,

Published
19 November 2004
By
Christopher Gadd
Testing and health monitoring
ICAAC: Mitochondrial DNA level in blood may provide early warning of lipodystrophy

People with low mitochondrial DNA content in their blood after 48 weeks of treatment with either AZT (zidovudine, Retrovir) / 3TC (lamivudine, Epivir) or d4T

Published
30 October 2004
By
Keith Alcorn
How HIV works
AZT & d4T damage fat cells long before fat loss visible

AZT (zidovudine, Retrovir) and d4T (stavudine, Zerit) begin to cause damage to fat cells (adipose cells) long before physical signs of fat wasting appear, according

Published
28 October 2004
By
Keith Alcorn
← Prev1...3334353637Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.